Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-5.02
↑ 51% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-10.24
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -5.02 | -51.5% |
| 2024 | -3.31 | +36.6% |
| 2023 | -5.23 | -103.6% |
| 2022 | -2.57 | +56.7% |
| 2021 | -5.94 | +75.9% |
| 2020 | -24.63 | +30.3% |
| 2019 | -35.32 | -28170.2% |
| 2018 | 0.13 | - |